journal article·2023-04-17Open access

A Dynamic In Vitro Model for Testing Intestinal Absorption of Different Vegetable Food Secondary Metabolites

Raffaella Colombo, Mayra Paolillo, Adele Papetti

Applied Sciences· Volume 13· Issue 8

Abstract

Cell-based bioreactors are important tools for evaluating molecule absorption in dynamic conditions, simulating simil-physiological flow, transport, and biological barriers. They allow for absorption and metabolization studies to be performed, obtaining very predictive data of in vivo conditions. In this paper, a new dynamic model is proposed to evaluate the intestinal absorption and toxicity of different vegetable food secondary metabolites, by using a LiveFlow® bioreactor. Different food secondary metabolites, such as caffeic, quinic, and rosmarinic acids, quercetin, and rutin, belonging to the polyphenols class, were selected. The aim was to study their different intestinal absorptions in order to validate this new system as an alternative strategy or a more advanced method compared to conventional culture systems for absorption screening and testing. The molecule absorption and the potential generation of metabolites were evaluated by RP-HPLC-DAD. This new dynamic platform represents a promising in vitro methodology which can provide more information than the traditional static in vitro approaches, and an efficient alternative to animal models, at least in preliminary experiments.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Biochemical Analysis and Sensing Techniques · Postharvest Quality and Shelf Life Management · Microbial Inactivation Methods

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Drug Sciences, University of Pavia, V. le Taramelli 12, 27100 Pavia, Italy

C.S.G.I., Center for Colloid and Surface Science, 16, 27100 Pavia, Italy

References (59)

Show source-provided references
1. Changes in bioactive compounds and antioxidant activity of plant-based foods by gastrointestinal digestion: A review10.1080/10408398.2021.1878100 ↗
2. Verhoeckx, K., Cotter, P., López-Expósito, I., Kleiveland, C., Lea, T., Mackie, A., Requena, T., Swiatecka, D., and Wichers, H. (2015). The Impact of Food Bio-Actives on Gut Health: In Vitro and Ex Vivo Models, Springer.10.1007/978-3-319-16104-4 ↗
3. In vitro digestion models suitable for foods: Opportunities for new fields of application and challenges10.1016/j.foodres.2018.02.055 ↗
4. Comparison of five in vitro digestion models to in vivo experimental results: Lead bioaccessibility in the human gastrointestinal tract10.1080/10934520701434919 ↗
5. In vitro human digestion models for food applications10.1016/j.foodchem.2010.08.036 ↗
6. Advances in static in vitro digestion models after the COST action Infogest consensus protocol10.1039/D1FO01089A ↗
7. A standardized static in vitro digestion method suitable for food—An international consensus10.1039/C3FO60702J ↗
8. Infogest static in vitro simulation of gastrointestinal food digestion10.1038/s41596-018-0119-1 ↗
9. (2023, March 27). Cost-Infogest.eu. Available online: http://www.cost-infogest.eu.
10. Physiological comparability of the harmonized INFOGEST in vitro digestion method to in vivo pig digestion10.1016/j.foodres.2017.09.047 ↗
11. Investigations on the reactions of α-dicarbonyl compounds with amino acids and proteins during in vitro digestion of biscuits
12. The harmonized INFOGEST in vitro digestion method: From knowledge to action10.1016/j.foodres.2015.12.006 ↗
13. A first step towards a consensus static in vitro model for simulating full-term infant digestion10.1016/j.foodchem.2017.07.145 ↗
14. In vitro digestion models to assess lipolysis: The impact of the simulated conditions of gastric and intestinal pH, bile salts and digestive fluids10.1016/j.foodres.2019.108511 ↗
15. Co-cultures of human intestinal goblet (HT29-H) and absorptive (Caco-2) cells for studies of drug and peptide abs orption10.1016/0928-0987(95)00007-Z ↗
16. Intestinal permeability and its relevance for absorption and elimination10.1080/00498250701704819 ↗
17. Comprehensive characterization and optimization of Caco-2 cells enabled the development of a miniaturized 96-well permeability assay10.1080/00498254.2022.2133648 ↗
18. A multicompartmental dynamic computer-controlled model simulating the stomach and small intestine10.1177/026119299502300205 ↗
19. A Human Gastric Simulator (HGS) to study food digestion in human stomach10.1111/j.1750-3841.2010.01856.x ↗
20. The design, operation, and application of a dynamic gastric model10.14227/DT190312P15 ↗
21. Microengineered physiological biomimicry: Organs-on-chips10.1039/c2lc40089h ↗
22. Three-dimensional in vitro cell culture models in drug discovery and drug repositioning10.3389/fphar.2018.00006 ↗
23. Antolli, P.G., and Liu, Z. (2011). Bioreactors: Design, Properties and Applications, Nova Science Publishers.
24. A novel dual-flow bioreactor simulates increased fluorescein permeability in epithelial tissue barriers10.1002/biot.201400004 ↗
25. In vitro models of the small intestine for studying intestinal diseases10.3389/fmicb.2021.767038 ↗
26. Carton, F., and Malatesta, M. (2022). In vitro models of biological barriers for nanomedical research. Int. J. Mol. Sci., 23.10.3390/ijms23168910 ↗
27. In vitro models replicating the human intestinal epithelium for absorption and metabolism studies: A systematic review10.1016/j.jconrel.2021.05.028 ↗
28. Real-time cellular impedance monitoring and imaging of biological barriers in a dual-flow membrane bioreactor10.1016/j.bios.2019.111340 ↗
29. Costa, J., Almonti, V., Cacopardo, L., Poli, D., Rapposelli, S., and Ahluwalia, A. (2020). Investigating curcumin/intestinal epithelium interaction in a millifluidic bioreactor. Bioengineering, 7.10.3390/bioengineering7030100 ↗
30. A new millifluidic-based gastrointestinal platform to evaluate the effect of simulated dietary methylglyoxal intakes10.1039/C9FO00332K ↗
31. Effect of the simulated digestion process on the chlorogenic acid trapping activity against methylglyoxal10.1039/D2FO02778J ↗
32. (2022, January 15). ICH Guideline Q2(R1), Validation of Analytical Procedures: Text and Methodology Guidance for Industry, Available online: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/q2r1-validation-analytical-procedures-text-and-methodology-guidance-industry.
33. Dietary polyphenols and their role in oxidative stress-induced human diseases: Insights into protective effects, antioxidant potentials and mechanism(s) of action10.3389/fphar.2022.806470 ↗
34. Potential therapeutic implications of caffeic acid in cancer signaling: Past, present, and future10.3389/fphar.2022.845871 ↗
35. Dietary polyphenols alleviate autoimmune liver disease by mediating the intestinal microenvironment: Challenges and hopes10.1021/acs.jafc.2c02654 ↗
36. Flavonoids and the gastrointestinal tract: Local and systemic effects10.1016/j.mam.2018.01.001 ↗
37. Studies of intestinal permeability of 36 flavonoids using Caco-2 cell monolayer model10.1016/j.ijpharm.2008.09.023 ↗
38. In vitro digestion of dairy and egg products enriched with grape extracts: Effect of the food matrix on polyphenol bioaccessibility and antioxidant activity10.1016/j.foodres.2016.01.029 ↗
39. Bioaccessibility of Rutin, Caffeic Acid and Rosmarinic Acid: Influence of the in Vitro Gastrointestinal Digestion Models10.1016/j.jff.2016.08.003 ↗
40. TEER measurement techniques for in vitro barrier model systems10.1177/2211068214561025 ↗
41. Validation of HPLC–UV assay of caffeic acid in emulsions
42. Quantification of chlorogenic acid, rosmarinic acid, and caffeic acid contents in selected Thai medicinal plants using RP-HPLC-DAD10.1590/s2175-97902019000317547 ↗
43. Identification of organic acids in Cichorium intybus inhibiting virulence-related properties of oral pathogenic bacteria10.1016/j.foodchem.2012.10.148 ↗
44. Quantitative analysis of quercetin in euphorbia helioscopia L by RP-HPLC10.1007/s12013-011-9161-0 ↗
45. Human gastric emptying and colonic filling of solids characterized by a new method
46. Demonstrating the involvement of an active efflux mechanism in the intestinal absorption of chlorogenic acid and quinic acid using a Caco-2 bidirectional permeability assay10.1039/D0FO02629H ↗
47. Coordination of α-hydroxycarboxylic acids with first-row transition ions10.1016/j.ccr.2013.01.029 ↗
48. Novel coordination compounds of quinic acid. X-ray diffraction study of copper (II) complexes where the metal ion was a chiral centre10.1007/BF00980406 ↗
49. Bioavailability of caffeic acid in rats and its absorption properties in the Caco-2 cell model10.3109/13880209.2013.879906 ↗
50. Caffeic acid: A brief overview of its presence, metabolism, and bioactivity
51. Veras, K.S., Fachel, F.N.S., de Araújo, B.V., Teixeira, H.F., and Koester, L.S. (2022). Oral pharmacokinetics of hydroxycinnamic acids: An updated erview. Pharmaceutics, 14.10.3390/pharmaceutics14122663 ↗
52. Transepithelial transport of rosmarinic acid in intestinal Caco-2 cell monolayers10.1271/bbb.69.583 ↗
53. Permeability of rosmarinic acid in Prunella vulgaris and ursolic acid in Salvia officinalis extracts across Caco-2 cell monolayers10.1016/j.jep.2011.07.037 ↗
54. Rosmarinic Acid—Pharmaceutical and Clinical Aspects10.1055/s-0035-1568274 ↗
55. Stability of rosmarinic acid in aqueous extracts from different lamiaceae species after in vitro digestion with human gastrointestinal enzymes
56. Simultaneous determination and pharmacokinetic comparisons of multi-ingredients after oral administration of radix salviae miltiorrhizae extract, hawthorn extract, and a combination of both extracts to rats10.1155/2014/617367 ↗
57. In vitro digestion and lactase treatment influence uptake of quercetin and quercetin glucoside by the Caco-2 cell monolayer10.1186/1475-2891-4-1 ↗
58. Transport of quercetin and its glucosides across human intestinal epithelial Caco-2 cells10.1016/S0006-2952(98)00048-3 ↗
59. Absorption and metabolism characteristics of rutin in Caco-2 cells10.1155/2013/382350 ↗